Propensity Score Analysis: Hyper-CVAD (HCVAD) + Ponatinib vs. HCVAD + Dasatinib in Patients (Pts) with Philadelphia Chromosome-Positive (Ph+) ALL (ALL)
2016 ◽
Vol 34
(15_suppl)
◽
pp. 7025-7025
◽